MARTHA J DEMSKI
CIK 1198230 · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$515.1K
Companies
6
Total Filings
66
Lifetime Open-Market Net
-$821.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TKNO | Director | 12,000 | $4.20 | $50.4K | -$40.5K | 6 | 2026-06-02 |
| EQ | Director | — | $2.81 | — | $0 | 9 | 2026-05-29 |
| CHIMERIX INC (CMRX) Delisted | Director | 0 | $8.54 | $0 | -$781.3K | 32 | 2025-04-21 |
| ADMA | Director | 56,601 | $8.21 | $464.7K | $10.8K | 6 | 2023-03-08 |
| Adamas Pharmaceuticals Inc (ADMS) Delisted | Director | 0 | $8.22 | $0 | -$10.3K | 9 | 2021-11-24 |
| Evofem Biosciences, Inc. (NEOT) Delisted | Director | 16,393 | — | — | $0 | 4 | 2017-06-21 |
Recent Filings · Page 4 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-10 | CHIMERIX INC (CMRX) Delisted | Mixed | — | -$549 | EDGAR |
| 2020-08-06 | CHIMERIX INC (CMRX) Delisted | Mixed | — | -$737 | EDGAR |
| 2020-06-18 | ADMA | Grant (A) | — | $0 | EDGAR |
| 2020-06-15 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-05 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2020-05-21 | EQ | Grant (A) | — | $0 | EDGAR |
| 2019-06-24 | CHIMERIX INC (CMRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-13 | EQ | Grant (A) | — | $0 | EDGAR |
| 2019-06-06 | Adamas Pharmaceuticals Inc (ADMS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-29 | CHIMERIX INC (CMRX) Delisted | Buy (P) | +18,000 | $64.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.